SI2321273T1 - Enkrat tedensko dajanje 25-hidroksi-vitamina D3 za vzdrževanje povišane stacionarne farmakokinetične krvne koncentracije - Google Patents

Enkrat tedensko dajanje 25-hidroksi-vitamina D3 za vzdrževanje povišane stacionarne farmakokinetične krvne koncentracije

Info

Publication number
SI2321273T1
SI2321273T1 SI200931127T SI200931127T SI2321273T1 SI 2321273 T1 SI2321273 T1 SI 2321273T1 SI 200931127 T SI200931127 T SI 200931127T SI 200931127 T SI200931127 T SI 200931127T SI 2321273 T1 SI2321273 T1 SI 2321273T1
Authority
SI
Slovenia
Prior art keywords
once
blood concentration
hydroxy vitamin
week administration
state pharmacokinetic
Prior art date
Application number
SI200931127T
Other languages
English (en)
Inventor
Hector F. Deluca
Lori A. Plum
Margaret Clagett-Dame
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of SI2321273T1 publication Critical patent/SI2321273T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
SI200931127T 2008-07-24 2009-07-24 Enkrat tedensko dajanje 25-hidroksi-vitamina D3 za vzdrževanje povišane stacionarne farmakokinetične krvne koncentracije SI2321273T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8322308P 2008-07-24 2008-07-24
PCT/US2009/051664 WO2010011906A1 (en) 2008-07-24 2009-07-24 Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
EP09801055.6A EP2321273B1 (en) 2008-07-24 2009-07-24 Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration

Publications (1)

Publication Number Publication Date
SI2321273T1 true SI2321273T1 (sl) 2015-03-31

Family

ID=41570618

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200931127T SI2321273T1 (sl) 2008-07-24 2009-07-24 Enkrat tedensko dajanje 25-hidroksi-vitamina D3 za vzdrževanje povišane stacionarne farmakokinetične krvne koncentracije

Country Status (13)

Country Link
US (4) US8759328B2 (sl)
EP (1) EP2321273B1 (sl)
JP (2) JP6095891B2 (sl)
AU (1) AU2009273889B2 (sl)
CA (1) CA2731382C (sl)
DK (1) DK2321273T3 (sl)
ES (1) ES2525180T3 (sl)
HR (1) HRP20150093T1 (sl)
PL (1) PL2321273T3 (sl)
PT (1) PT2321273E (sl)
SI (1) SI2321273T1 (sl)
SM (1) SMT201500020B (sl)
WO (1) WO2010011906A1 (sl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2640094C (en) 2006-02-03 2015-04-14 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
PT3357496T (pt) 2006-06-21 2020-05-12 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
EP2148683A4 (en) 2007-04-25 2012-09-12 Proventiv Therapeutics Llc METHOD FOR THE SAFE AND EFFECTIVE TREATMENT AND PREVENTION OF SECONDARY HYPERPARATHYREOSIS IN CHRONIC KIDNEY DISEASE
WO2008134518A2 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
JP5501956B2 (ja) 2007-04-25 2014-05-28 シトクロマ インコーポレイテッド ビタミンｄ化合物およびワックス状担体を含有する制御放出性経口組成物
CN101668532B (zh) 2007-04-25 2014-08-20 赛特克罗公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途
CA2714996C (en) 2008-04-02 2020-04-07 Cytochroma Inc. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
ES2525180T3 (es) * 2008-07-24 2014-12-18 Wisconsin Alumni Research Foundation Administración semanal de 25-hidroxi-vitamina D3 para mantener una concentración en sangre con farmacocinética en estado de equilibrio elevada
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
US10055727B2 (en) 2012-11-05 2018-08-21 Mfoundry, Inc. Cloud-based systems and methods for providing consumer financial data
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US20140296190A1 (en) * 2013-03-27 2014-10-02 Dsm Ip Assets B.V. Marketing the use of 25-hydroxyvitamin d3 to enhance cognition
WO2015102996A1 (en) * 2013-12-31 2015-07-09 Grasso Frank J Extremely high loading dose
AU2015298858A1 (en) * 2014-08-07 2017-03-02 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin D
EP3053598A1 (en) 2015-02-06 2016-08-10 Faes Farma, S.A. Calcifediol soft capsules
JP6910608B2 (ja) * 2016-01-20 2021-07-28 国立大学法人島根大学 医療従事者用ヘッドライト
IL290855B1 (en) 2016-03-28 2024-02-01 Eirgen Pharma Ltd Treatment methods using vitamin D
CN108383767B (zh) * 2018-02-06 2020-03-24 山东海能生物工程有限公司 25-羟基胆钙化醇一水合物晶体及其制备方法以及使用其的微乳液
WO2022006446A1 (en) * 2020-07-02 2022-01-06 The Uab Research Foundation Compositions and methods of treating conditions
WO2022224001A1 (en) * 2021-04-22 2022-10-27 Faes Farma, S.A. Universal dosage regime of 25-hydroxy vitamin d3

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607888A (en) 1969-08-07 1971-09-21 Wisconsin Alumni Res Found 25-hydroxytachysterol3 25-hydroxydihydrotachysterol3 and methods for preparing same
ATE187332T1 (de) * 1992-09-15 1999-12-15 Thys Jacobs Susan Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium
US7632518B2 (en) * 2002-01-15 2009-12-15 Dsm Ip Assets B.V. 25-hydroxy vitamin D3 compositions
US20050176685A1 (en) * 2002-04-05 2005-08-11 Daifotis Anastasia G. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
US20050101576A1 (en) * 2003-11-06 2005-05-12 Novacea, Inc. Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
US7862834B2 (en) 2003-05-28 2011-01-04 Novartis Pharma Ag Pharmaceutical formulation comprising a water-insoluble active agent
CA2640094C (en) * 2006-02-03 2015-04-14 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
PT3357496T (pt) * 2006-06-21 2020-05-12 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
JP5501956B2 (ja) * 2007-04-25 2014-05-28 シトクロマ インコーポレイテッド ビタミンｄ化合物およびワックス状担体を含有する制御放出性経口組成物
CN101668532B (zh) * 2007-04-25 2014-08-20 赛特克罗公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途
WO2008134518A2 (en) * 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
BRPI0907953A2 (pt) * 2008-02-13 2015-08-04 Dsm Ip Assets Bv Uso de 25-hidroxivitamina d3 para afetar a fisiologia do músculo humano
ES2525180T3 (es) * 2008-07-24 2014-12-18 Wisconsin Alumni Research Foundation Administración semanal de 25-hidroxi-vitamina D3 para mantener una concentración en sangre con farmacocinética en estado de equilibrio elevada
CN105796530A (zh) * 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物

Also Published As

Publication number Publication date
SMT201500020B (it) 2015-03-05
PL2321273T3 (pl) 2015-05-29
JP2011529081A (ja) 2011-12-01
EP2321273A1 (en) 2011-05-18
ES2525180T3 (es) 2014-12-18
CA2731382C (en) 2020-04-28
EP2321273B1 (en) 2014-11-19
AU2009273889B2 (en) 2013-01-31
CA2731382A1 (en) 2010-01-28
WO2010011906A1 (en) 2010-01-28
JP6095891B2 (ja) 2017-03-15
US20200281947A1 (en) 2020-09-10
EP2321273A4 (en) 2011-11-30
US20150374722A1 (en) 2015-12-31
AU2009273889A1 (en) 2010-01-28
DK2321273T3 (en) 2015-02-16
US8759328B2 (en) 2014-06-24
JP6375353B2 (ja) 2018-08-15
US20110105444A1 (en) 2011-05-05
PT2321273E (pt) 2014-12-29
JP2017061545A (ja) 2017-03-30
US20140100203A1 (en) 2014-04-10
HRP20150093T1 (hr) 2015-03-27

Similar Documents

Publication Publication Date Title
HRP20150093T1 (hr) Tjedna administracija 25-hidroksi vitamina d3 za održavanje povišene koncentracije u krvi pri stacionarnoj farmakokinetici
HK1212210A1 (en) Combined use of 25-hydroxy-vitamin d3 and vitamin d3 d3 25-- d3
PT2334295T (pt) Composição farmacêutica compreendendo ácido eicosapentanoico e ácido nicotínico e métodos de utilização dos mesmos
EP2188259A4 (en) PROCESS FOR THE PREPARATION AND ADMINISTRATION OF CHINOLINE DERIVATIVES AS ANTICROBIAL AGENTS
IL207621A0 (en) Linking visual properties of charts to cells within tables
EP2346430A4 (en) ECCENTRIC BALLOON LASER CATHETER
EP2519230A4 (en) MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM AND PHARMACOKINETIC PROFILE OF LIPOPHILIC ACTIVE SUBSTANCES USING STEROLS
EP2271347A4 (en) ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
IL206835A0 (en) Methods and compositions for oral administration of insulin
EP2214715A4 (en) METHOD OF ADMINISTERING AN ANTI-CANCER AGENT TO A CELL
AP2627A (en) New form of administration of racecadotril
IL207589A0 (en) Combination of vitamin d and 25-hydroxyvitamin d3
PL3005986T3 (pl) Infuzja leków
HK1154200A1 (en) Vitamin compositions and method of administration to a human being
IL207049A0 (en) Synthesis of resorcylic acid lactones useful as therapeutic agents
WO2010132347A9 (en) Docosahexaenoic acid for the treatment of heart failure
EP2431038A4 (en) PHARMACEUTICAL COMPOSITION WITH ARBIDOL IN THE FORM OF PHOSPHOLIPID NANOPARTICLES
IL212603A0 (en) Combined drug administration
HK1152247A1 (en) Methods of treatment employing prolonged continuous infusion of belinostat belinostat
EP2276478A4 (en) METHOD FOR THE ADMINISTRATION OF PROSTRATIN AND STRUCTURAL ANALOGUE THEREOF
PL389431A1 (pl) Kompozycja liposomowa zawierająca pochodne witaminy B3
HU0800679D0 (en) Technology for production of fire-fighting power
UA63226U (en) Pancreatonecrosis simulation method
PL117809U1 (pl) Dzielona stopa słupka uchylnego dwukierunkowo